Compare Davita Inc (DVA) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs D Wave Quantum Inc — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while D Wave Quantum Inc trades at $20.38 (market cap $7.52B). The key difference: Davita Inc is the larger of the two by market cap, and Davita Inc is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals.
| DVA | QBTS | |
|---|---|---|
Market Cap | $11.72B | $7.52B |
Sector | Health | Technology |
52-Week High | $240.96 | $44.78 |
52-Week Low | $103.87 | $12.98 |
Enterprise Value | $24.44B | $7.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
D-Wave Quantum (QBTS) trades at $20.74, up 6.85% today, with strong bullish technical signals from moving averages. The stock shows extreme valuation metrics with P/S of 582.68 and negative profitability, though 100% of analysts maintain buy ratings with a $38.78 consensus target. Recent Q2 2026 results missed revenue expectations but showed a 1,120% surge in bookings, highlighting the speculative growth nature of this quantum computing play.
The outlook remains speculative with significant execution risk given negative cash flows and mounting losses, but potential exists if quantum computing adoption accelerates. Investors face high volatility amid ongoing operational losses despite strong analyst conviction and institutional interest in this emerging technology sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
